Lyra Therapeutics Inc (LYRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 33,755 | 45,747 | 58,131 | 69,046 | 66,105 |
| Receivables | 5,000 | N/A | N/A | N/A | N/A |
| TOTAL | $40,555 | $47,918 | $60,886 | $70,073 | $67,351 |
| Non-Current Assets | |||||
| PPE Net | 4,275 | 4,503 | 4,706 | 3,853 | 3,168 |
| Other Non-Current Assets | 2,515 | 2,446 | 2,170 | 2,406 | 2,398 |
| TOTAL | $6,790 | $6,949 | $6,876 | $6,259 | $5,566 |
| Total Assets | $47,345 | $54,867 | $67,762 | $76,332 | $72,917 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,408 | 3,125 | 2,912 | 1,899 | 1,169 |
| Accrued Expenses | 4,237 | 4,258 | 3,968 | 2,976 | 1,994 |
| TOTAL | $21,965 | $18,246 | $17,773 | $5,904 | $4,170 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 14,223 | 9,789 | 9,841 | N/A | N/A |
| Other Non-Current Liabilities | 99 | 379 | 656 | 929 | 1,196 |
| TOTAL | $2,123 | $2,305 | $2,801 | $12,929 | $1,196 |
| Total Liabilities | $24,088 | $20,551 | $20,574 | $18,833 | $5,366 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 637 | 260 | 260 | 260 | 260 |
| Common Shares | 13 | 13 | 13 | 13 | 13 |
| Retained earnings | -205,308 | -193,397 | -179,780 | -168,725 | -157,686 |
| TOTAL | $23,257 | $34,316 | $47,188 | $57,499 | $67,551 |
| Total Liabilities And Equity | $47,345 | $54,867 | $67,762 | $76,332 | $72,917 |